4D MOLECULAR THERAPEUTICS IN

Ticker: FDMT CUSIP: 35104E100 Class: Common Stock

Soleus Capital Management, L.P.'s Holding History (CIK: 0001802630)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 108,598 Value ($000) $2,279 Avg Close $25.09 Range $20.33 - $31.87
Q1 2024
Shares 197,098 Value ($000) $6,280 Avg Close $25.51 Range $16.64 - $36.25
Q4 2023
Shares 45,748 Value ($000) $927 Avg Close $13.16 Range $9.44 - $21.53
Q3 2023
Shares 123,748 Value ($000) $1,575 Avg Close $16.73 Range $12.34 - $20.47
Q2 2023
Shares 219,148 Value ($000) $3,960 Avg Close $18.41 Range $13.26 - $24.10
Q1 2023
Shares 469,400 Value ($000) $8,069 Avg Close $19.45 Range $14.67 - $23.81
Q4 2022
Shares 254,700 Value ($000) $5,657 Avg Close $15.45 Range $6.58 - $26.49
Q3 2021
Shares 120,900 Value ($000) $3,261 Avg Close $28.52 Range $22.20 - $36.14
Q2 2021
Shares 100,800 Value ($000) $2,427 Avg Close $30.61 Range $21.40 - $44.03
Q1 2021
Shares 86,100 Value ($000) $3,735 Avg Close $44.29 Range $34.00 - $55.11